AirAvant Medical is a DBA of InnoMed Healthscience, Inc., focusing on non-surgical and non-implantable methods for addressing breathing disorders, such as obstructive sleep apnea, snoring, and COPD applications. Creators of Bongo Rx, this respiratory product is intended to treat obstructive sleep apnea (OSA). AirAvant Medical strives for better breathing solutions that do not require oral appliances, suction, or negative pressure systems - products that are lower risk, beneficial, and convenient. AirAvant Medical has succeeded in creating a revolutionary, FDA cleared sleep apnea therapy device. Clinical testing has been conducted to demonstrate the safety and effectiveness of the Bongo Rx for treating mild to moderate obstructive sleep apnea (OSA). In clinical testing, the results demonstrated that the Apnea-Hypopnea Index (AHI) was significantly reduced with the Bongo Rx compared to the baseline diagnostic. There were no serious adverse events. The Bongo Rx has soft nasal seals to form a seal within the nasal openings. During inhalation, small valves open to allow you to breathe normally through the device. During exhalation, the valves close directing exhaled air through specifically designed vent holes to generate EPAP (Expiratory Positive Airway Pressure), which props open the airway until you inhale again.